🇺🇸 NUTROF TOTAL in United States

28 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Condition Aggravated — 5 reports (17.86%)
  2. Cataract — 3 reports (10.71%)
  3. Diarrhoea — 3 reports (10.71%)
  4. Eosinophilia — 3 reports (10.71%)
  5. Fatigue — 3 reports (10.71%)
  6. Visual Acuity Reduced — 3 reports (10.71%)
  7. Acute Kidney Injury — 2 reports (7.14%)
  8. Blood Creatine Abnormal — 2 reports (7.14%)
  9. Confusional State — 2 reports (7.14%)
  10. Constipation — 2 reports (7.14%)

Source database →

NUTROF TOTAL in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is NUTROF TOTAL approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for NUTROF TOTAL in United States?

Insel Gruppe AG, University Hospital Bern is the originator. The local marketing authorisation holder may differ — check the official source linked above.